109.30 -1.35 (-1.22%)

51.21% Fall from 52W High

192.3K NSE+BSE Volume

NSEJul 27, 2021 03:31 PM



Bliss GVS Pharma Ltd.    
23 Jul 2021
109.30
-1.22%
Bliss GVS Pharma Ltd - 506197 - Board Meeting Intimation for Board Meeting Intimation For Unaudited ...
BSE India
BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Saturday, July 31, 2021 at the registered office of the Company to consider and approve, inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2021. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2021 and shall remain closed till 48 hours after the announcement/declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021.
default
Bliss GVS Pharma Ltd.    
20 Jul 2021
109.30
-1.22%
BLISS GVS PHARMA LTD. - 506197 - Shareholding for the Period Ended June 30, 2021
BSE India
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
Bliss GVS Pharma Ltd.    
20 Jul 2021
109.30
-1.22%
Bliss GVS Pharma Ltd - 506197 - Statement Of Investor Complaints For The Quarter Ended June 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Aditi BhattDesignation :- Company Secretary and Compliance Officer
Bliss GVS Pharma Ltd.    
14 Jul 2021
109.30
-1.22%
default
Bliss GVS Pharma Ltd.    
09 Jul 2021
109.30
-1.22%
Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE India
In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of newspaper advertisement of notice published in The Free Press Journal (English) and Navshakti (Regional) on July 09, 2021, concerning the proposed transfer of unclaimed final dividend 2013-2014 and its corresponding shares to IEPF Authority, pursuant to Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time.
Bliss GVS Pharma Ltd.    
09 Jul 2021
109.30
-1.22%
Bliss GVS Pharma Ltd - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend ...
BSE India
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copy of the communication sent to those concerned shareholders, whose dividend have remain unclaimed for a period of seven consecutive years or more, concerning the proposed transfer of unclaimed final dividend 2013-2014 and its corresponding shares to the IEPF Authority in pursuance of section 124(6) of the Companies Act, 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
Bliss GVS Pharma Ltd.    
09 Jul 2021
109.30
-1.22%
BLISS GVS PHARMA LTD. - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Final Dividend ...
BSE India
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copy of the communication sent to those concerned shareholders, whose dividend have remain unclaimed for a period of seven consecutive years or more, concerning the proposed transfer of unclaimed final dividend 2013-2014 and its corresponding shares to the IEPF Authority in pursuance of section 124(6) of the Companies Act, 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
Bliss GVS Pharma Ltd.    
30 Jun 2021
109.30
-1.22%
Bliss GVS Pharma Ltd - 506197 - Compliances-Reg.24(A)-Annual Secretarial Compliance
BSE India
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed herewith Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2021. This is for your information and record.
Bliss GVS Pharma Ltd.    
30 Jun 2021
109.30
-1.22%
BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window
BSE India
This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Thursday, July 01, 2021 until 48 hours after the announcement of the Unaudited financial results of the Company for the quarter ended June 30, 2021.
Bliss GVS Pharma Ltd.    
10 Jun 2021
109.30
-1.22%
Total Votes: 73
BUY
SELL
HOLD
79.45%
12.33%
8.22%